| 1.92 -0.04 (-2.04%) | 12-08 15:48 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.44  |
1-year : | 2.73 |
| Resists | First : | 2.09 |
Second : | 2.33 |
| Pivot price | 1.97 |
|||
| Supports | First : | 1.7 |
Second : | 1.41 |
| MAs | MA(5) : | 1.99 |
MA(20) : | 1.94 |
| MA(100) : | 2.85 |
MA(250) : | 2.47 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 38.8 |
D(3) : | 44.9 |
| RSI | RSI(14): 42.7 |
|||
| 52-week | High : | 15.52 | Low : | 0.63 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AHI ] has closed above bottom band by 37.5%. Bollinger Bands are 51.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 77 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.02 - 2.04 | 2.04 - 2.05 |
| Low: | 1.86 - 1.88 | 1.88 - 1.89 |
| Close: | 1.89 - 1.92 | 1.92 - 1.94 |
Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.
Fri, 03 Nov 2023
Advanced Health Intelligence Signs Binding Term Sheet with Electronic Medical Record and Global Personal Health ... - Marketscreener.com
Wed, 02 Aug 2023
Advanced Health Intelligence to re-enter China with Exclusive License Deal with Changlin Network Technology Ltd - Yahoo Finance
Wed, 21 Jun 2023
Should You Buy Advanced Health Intelligence Ltd (AHI) Stock After it Is Down 50.67% in a Week? - InvestorsObserver
Wed, 21 Jun 2023
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.30% By Investing.com - Investing.com
Wed, 14 Jun 2023
Why has the Advanced Health Intelligence share price rocketed 370% this week? - The Motley Fool Australia
Tue, 13 Jun 2023
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.43% By Investing.com - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software—Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 1.5406e+008 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 113 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.029e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 53.4 % |
| Return on Equity (ttm) | -66.2 % |
| Qtrly Rev. Growth | 654840 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -148.72 |
| EBITDA (p.s.) | -3.53988e+006 |
| Qtrly Earnings Growth | -0.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 312.95 |
| Dividend | 0 |
| Forward Dividend | 62230 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|